Gamida Cell Inc.

1 FDA products 1 active ingredients HUMAN PRESCRIPTION DRUG

Gamida Cell Inc. is listed as the manufacturer on 1 FDA drug label records covering 1 distinct active ingredients predominantly human prescription drug products.

About Gamida Cell Inc.

Gamida Cell Inc. is named as the labeler on 1 FDA drug label records. Its catalogue spans 1 distinct active ingredients, led by MOTIXAFORTIDE. Most of these labels are human prescription drug products. Labelling across this portfolio most often references: hematopoietic stem, indicated combination, filgrastim g-csf, peripheral blood, subsequent autologous, transplantation patients, multiple myeloma, usage aphexda. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.

Active ingredients in this portfolio

Active ingredientProducts
MOTIXAFORTIDE 1

Dosage forms and routes

Dosage formProductsRouteProducts
— — SUBCUTANEOUS 1
— — — —
— — — —
— — — —
— — — —
— — — —

FDA drug products from Gamida Cell Inc.

Brand nameGenericTypeRoute
APHEXDA MOTIXAFORTIDE HUMAN PRESCRIPTION DRUG SUBCUTANEOUS

Frequently asked questions

How many FDA drug products does Gamida Cell Inc. make?
1 FDA drug label records name Gamida Cell Inc. as the manufacturer, covering 1 distinct active ingredients.

What active ingredients does Gamida Cell Inc. produce?
The most frequent active ingredients in this portfolio are MOTIXAFORTIDE.

Are Gamida Cell Inc. products prescription or over-the-counter?
The largest share of this company’s labels are human prescription drug products; check each product page for its own marketing status.

Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.

Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.